- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.06. | Novo Nordisk's Wegovy approved as UK's first daily GLP-1 weight loss pill | ||
| 12.06. | Obesity care in the UK - why it can't improve until it is recognised as a disease | ||
| 11.06. | Roche's Tecentriq gets FDA Priority Review for specific stage 3 colon cancer | ||
| 11.06. | Oriva Therapeutics appoints Agnès Arbat as CEO | ||
| 10.06. | Lilly's Ebglyss approved by FDA as maintenance dose for atopic dermatitis | ||
| 10.06. | The next frontier in clinical trials: navigating multi-disease research with GLP-1s | ||
| 09.06. | CSL's Privigen approved as measles treatment by European Commission | ||
| 09.06. | GSK to acquire biopharma Nuvalent for $10.6bn | ||
| 08.06. | Roche and Nurix Therapeutics to partner in $2.3bn deal | ||
| 08.06. | Headline trade and market deals are opening doors to greater patient access | ||
| 05.06. | Biogen's salanersen gets FDA Breakthrough Therapy Designation for SMA | ||
| 05.06. | Men's health: the gap between awareness and action is where men's lives are lost | ||
| 04.06. | Alnylam and Inceptive agree on $2bn AI collaboration | ||
| 04.06. | Ardena appoints Ariane de Ganck as Chief Scientific Officer | ||
| 03.06. | Bristol Myers Squibb and SystImmune announce phase 3 results for antibody-drug conjugate | ||
| 03.06. | VML Health appoints Jason Graff as Global CCO | ||
| 02.06. | J&J's Erleada prostate cancer study shows significant reduction in risk of metastasis | ||
| 02.06. | Gates Medical Research Institute appoints Charles Wells as Chief Medical Officer and Head of Medical Development | ||
| 01.06. | Pfizer and Innovent Biologics agree on deal worth up to $10.5bn | ||
| 01.06. | EMA celebrates diversity and inclusion in science and healthcare | ||
| 29.05. | GSK announces bepirovirsen's 'functional cure' data to treat chronic hepatitis B | ||
| 29.05. | The blind spot undermining pharma product launches - and how to eliminate it | ||
| 29.05. | Delphia Therapeutics appoints David Kerstein as Chief Medical Officer | ||
| 28.05. | Why HCP AI use is now a brand strategy opportunity for pharma | ||
| 28.05. | NICE recommends Genmab's Tivdak for recurrent or metastatic cervical cancer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.